Travers Smith private equity partner Paul Dolman has advised a newco funded by funds advised by Kester Capital LLP on the management buyout of Frontier Medical Products Limited ("Frontier").

Founded in 1966, Frontier has grown to become a leading manufacturer and supplier of pressure area care and infection control products to healthcare providers in the UK and continental Europe.  Frontier is based in Wales and employs over 250 people.

The Frontier management team, lead by Nick Davis and Nigel Harris, have re-invested alongside Kester Capital and the transaction has been supported by new loan facilities from the Royal Bank of Scotland plc.

The Travers Smith team included corporate associates Alex Dixon and Genevieve McDermott, tax partner Kathleen Russ and banking partner Matthew Ayre.  Frontier was advised by EY and Meade King.  RBS was advised by Osborne Clark.